
|Videos|November 13, 2015
Stopping Memantine or Cholinesterase in Dementia Patients
Kalin M. Clifford, PharmD, BCPS, discusses when treatment with memantine or cholinesterase should be stopped in patients with dementia.
Advertisement
Kalin M. Clifford, PharmD, BCPS, discusses when treatment with memantine or cholinesterase should be stopped in patients with dementia.
This video was recorded at ASCP's Annual Meeting and Exhibition in Las Vegas, Nevada in October 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
2
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer
3
FDA Approves Gazyva for Active Lupus Nephritis
4
Amivantamab Shows 45% Response Rate in Pretreated Head and Neck Cancer: OrigAMI-4 Findings
5